Alvotech Secures $965M Refinancing Deal to Boost Financial Flexibility and Support Product Launches
Alvotech (NASDAQ:ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the successful arrangement of a strategic refinancing